These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34423480)

  • 1. Prognostic and predictive role of a metabolic rate-limiting enzyme signature in hepatocellular carcinoma.
    Wang Z; Fu Y; Xia A; Chen C; Qu J; Xu G; Zou X; Wang Q; Wang S
    Cell Prolif; 2021 Oct; 54(10):e13117. PubMed ID: 34423480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.
    Wang X; Xing Z; Xu H; Yang H; Xing T
    Aging (Albany NY); 2021 Apr; 13(10):13822-13845. PubMed ID: 33929972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients.
    Wang Z; Zhang N; Lv J; Ma C; Gu J; Du Y; Qiu Y; Zhang Z; Li M; Jiang Y; Zhao J; Du H; Zhang Z; Lu W; Zhang Y
    Biomed Res Int; 2020; 2020():4037639. PubMed ID: 33163533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
    Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
    Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
    Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y
    Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.
    Zhang Z; Weng W; Huang W; Wu B; Zhou Y; Zhang J; Deng T; Ye W; Zhang J; Ao J; Zhang Q; Shi K
    Aging (Albany NY); 2020 Jun; 12(13):12896-12920. PubMed ID: 32611831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a RNA Binding Protein-Associated Prognostic Model for Hepatocellular Carcinoma.
    Wang M; Jiang F; Wei K; Wang J; Zhou G; Wu C; Yin G
    Technol Cancer Res Treat; 2021; 20():15330338211004936. PubMed ID: 33910445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma.
    Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q
    Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma.
    Wang X; Qiao J; Wang R
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma.
    Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B
    J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
    Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
    Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
    Zhen Z; Shen Z; Hu Y; Sun P
    Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.
    Liang JY; Wang DS; Lin HC; Chen XX; Yang H; Zheng Y; Li YH
    Int J Biol Sci; 2020; 16(13):2430-2441. PubMed ID: 32760210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients.
    Wang W; Zhang C; Yu Q; Zheng X; Yin C; Yan X; Liu G; Song Z
    BMC Gastroenterol; 2021 Feb; 21(1):68. PubMed ID: 33579192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma.
    Hui Y; Leng J; Jin D; Liu D; Wang G; Wang Q; Wang Y
    Dis Markers; 2021; 2021():1986159. PubMed ID: 34721731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.